Picture of MiMedx logo

MDXG MiMedx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapContrarian

MiMedx Group Inc reports results for the quarter ended in September - Earnings Summary

* MiMedx Group Inc  MDXG.OQ  reported a quarterly adjusted
loss
of 9 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 8 cents per share.
    * Revenue rose 7.3% to $67.69 million from a year ago;
analysts
expected $66.73 million. 
    * MiMedx Group Inc's reported EPS for the quarter was a loss
of 9
cents​.
    * The mean earnings estimate of analysts had fallen by
about 93.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * MiMedx Group Inc shares had risen by 5.2% this quarter and
lost 50.0% so far this year.
    * The company reported a quarterly loss of $10.1 million.
    * Wall Street's median 12-month price target for MiMedx
Group Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 12:02 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.08          -0.09          Missed
 Jun. 30 2022      -0.06          -0.11          Missed
 Mar. 31 2022      -0.10          -0.11          Missed
 Dec. 31 2021      -0.03          0.01           Beat

Recent news on MiMedx

See all news